decreased tumor incidence_Adam15<tm2.1Bbl>/Adam15<tm2.1Bbl>

http://metadb.riken.jp/0002052I129SvJ129P2OlaHsdC57BL6JSJLAdam15tm21BblAdam15tm21BblAdam15tm21Bbl

decreased tumor incidence_Adam15<tm2.1Bbl>/Adam15<tm2.1Bbl>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• a disintegrin and metallopeptidase domain 15 (metargidin)
  http://metadb.riken.jp/db/mgi_rdf/MGI:1333882

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Adam15<tm2.1Bbl>/Adam15<tm2.1Bbl>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Adam15<tm2.1Bbl>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129/SvJ * 129P2/OlaHsd * C57BL/6J * SJL

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased tumor incidence
  http://purl.obolibrary.org/obo/MP_0002052

文献

http://purl.org/net/cito/citesAsAuthority

• Thorsten. Maretzky, et.al., Characterization of oxygen-induced retinopathy in mice carrying an inactivating point mutation in the catalytic site of ADAM15., Investigative ophthalmology & visual science, 2014, 55
  http://rdf.ncbi.nlm.nih.gov/pubmed/25249606